Where's it on?
FDA · Drugs ·

Glycopyrrolate Injection recall

Fresenius Kabi USA, LLC recalled Glycopyrrolate Injection on July 29, 2026 because of presence of Particulate Matter: Hair was found in product. It was sold nationwide.

Why it was recalled

Presence of Particulate Matter: Hair was found in product

What's recalled

Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial: 63323-578-07

Quantity: 59,425 vials

What to do

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Read the official FDA notice